COVID - 19 Vaccination Update - Day 468 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 28 APR 2022 10:36PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 188.62 Crore (1,88,62,67,266) today. More than 20 lakh (20,40,131) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10405030
	2^nd Dose	10015368
	Precaution Dose	4775274
FLWs	1^st Dose	18415525
	2^nd Dose	17537616
	Precaution Dose	7540287
Age Group 12-14 years	1^st Dose	28233759
	2^nd Dose	5706680
Age Group 15-18 years	1^st Dose	58362553
	2^nd Dose	42053224
Age Group 18-44 years	1^st Dose	555666543
	2^nd Dose	477543278
	Precaution Dose	134565
Age Group 45-59 years	1^st Dose	202910791
	2^nd Dose	187818120
	Precaution Dose	480024
Over 60 years	1^st Dose	126858551
	2^nd Dose	117011274
	Precaution Dose	14798804
Cumulative 1^st dose administered		1000852752
Cumulative 2^nd dose administered		857685560
Precaution Dose		27728954
Total		1886267266

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 28^th April, 2022 (468^th Day)
HCWs	1^st Dose	53
	2^nd Dose	656
	Precaution Dose	18075
FLWs	1^st Dose	110
	2^nd Dose	1182
	Precaution Dose	42646
Age Group 12-14 years	1^st Dose	344479
	2^nd Dose	683381
Age Group 15-18 years	1^st Dose	49534
	2^nd Dose	143356
Age Group 18-44 years	1^st Dose	33289
	2^nd Dose	402002
	Precaution Dose	11213
Age Group 45-59 years	1^st Dose	4575
	2^nd Dose	86235
	Precaution Dose	38118
Over 60 years	1^st Dose	3602
	2^nd Dose	56403
	Precaution Dose	121222
Cumulative 1^st dose administered		435642
Cumulative 2^nd dose administered		1373215
Precaution Dose		231274
Total		2040131

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.